Indeed, to characterize the cell localization of TLRs interacting with SSc-ICs, endothelial cells have been pre-incubated with bafilomycin, an inhibitor of the vacuolar-type H+-ATPase, which prevents the activation of intra-cellular TLRs by interfering with endosomal acidification. Here, ATP6V1A is linked to systemic sclerosis.